An updated invitation with full agenda and practical information about participation is available here.
Deadline for registration: 1 Nov 2019.
After this date, please contact us at post@nordicclinicalgenomics.org.
Symposium:
Welcome and opening remarks
- Dag E. Undlien, Oslo University Hospital, NACG chair
- Kenneth Vareide, CEO Digital Solutions, DNV GL
- Paul Chaffey, State Secretary to the Minister of Digitalisation, Norway
National initiatives
- Key note speaker: Bettina Lundgren, Director of the Danish National Genome Centre
- Anna Lindstrand, Genomic Medicine Sweden / Karolinska Institute
- Aarno Palotie, research director of the Human Genomics program at FIMM, Finland
The European 1+ Million Genomes Initiative from a Norwegian perspective
- Grethe Synnøve Foss, project manager for the Norwegian Strategy for Personalised Medicine at the Directorate for Health and Care
Nordic Per Med Law initiative on the regulatory framework for personalised medicine
- Gjertrud Bøhn Mageli, Oslo University Hospital
Data sharing: Variant Exchange experiences – practical cross-border sharing
- Stephen McAdam, Digital Health Development Director, DNV GL
Next generation sequencing of Common and Rare diseases in Iceland
- Patrick Sulem, Head of Clinical sequencing, deCODE genetics Iceland
Clinical genomics at scale; lessons
from Illumina
- Paul Jones, Head of Population
Genomics, EMEA, Illumina
Genomic medicine in cancer & clinical trials
- Kristoffer Rohrberg, head of phase I unit, Rigshospitalet, Copenhagen
- Caroline Heckman, Institute for Molecular Medicine Finland (FIMM) / iCAN
- Valtteri Wirta, Facility director, SciLifeLab
Genomic medicine in cancer & clinical trials – precision drugs
- James Hadfield, Director and Principal Diagnostic
Scientist, Precision Medicine Laboratories at
AstraZeneca
- Duarte Marchand, Country Manager for Takeda
Genomic medicine in cancer & clinical trials
- Panel discussion with speakers from the morning session, moderated by Valtteri Wirta.
Workshops:
- Consent
- Facilitated by Sharmini Alagaratnam, DNV GL and Kaisa Kettunen, FIMM
- This 3-hour
workshop aims to compare different approaches to consent in clinical genomics,
as well as to identify and discuss common challenges and unresolved issues
related specifically to the use of NGS in clinical diagnostics.
- Structural variants and Bioinformatic tools development (combined workstreams)
- Facilitated by Oleg Agafonov, DNV GL, Mads Bak, Rigshospitalet, Tony Håndstad, OUS AMG and Rasmus Lykke Marvig, Rigshospitalet
- In this
session, Nordic laboratories will share their experiences in using SVs for
clinical diagnostics. We will first examine SV calling methodology and compare
benchmarking results from different laboratories. Then we will go into more
detail on downstream processing, including tools and strategies for
clustering/merging results of multiple callers, annotation, and frequency
counting. Finally, we will discuss how to best visualize SVs and interpret
them.
- NGS for cancer diagnostics
- Facilitated by Vibeke Binz Vallevik and Courtney Nadeau, DNV GL
- This
session will examine topics related to the patient pathways, guidelines, and
technical pipelines for somatic sequencing in the Nordics. Preliminary data
from the
BigMed project, which has mapped molecular diagnostics supporting
cancer treatment at several Nordic hospitals, will be presented. The goal of
this workshop is to share an overview of routine somatic sequencing in the
different countries and to identify important topics to address through the
NACG forum.
- MDR and IVDR - how to address the upcoming regulations?
- Alex Shiryaev, DNV GL Presafe AS
- All actors involved with medical
devices, from their manufacture to their use, will have to comply with the new
regulations by May 2020 (May 2022 for in vitro diagnostic medical devices). This
session will provide an introduction to the European regulations on Medical
Devices (MDR) and In Vitro Diagnostics Medical Devices (IVDR), followed by a discussion
on applicability to hospital (lab) developed tests (LDTs) and preparations for
the transition.
Nordic
conference: The legal framework for personalised medicine
Adjacent to the NACG event (18.-19. Nov 2019) there will be a conference on The legal framework for personalised medicine (Rettslige reguleringer av persontilpasset medisin) organized at the same venue. For more information please visit the external event website. Deadline for registration: 25. Oct 2019
.